Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Archives of Internal Medicine|June 29, 2000
A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study GroupR Day, B Morrison, A Luza, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|May 6, 2017
Hyperpolarized gas diffusion MRI of biphasic lung inflation in short- and long-term emphysema modelsYi Xin, Maurizio Cereda, Stephen Kadlecek, et al.The Journal of Pharmacology and Experimental Therapeutics|August 10, 2017
Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G Yonchuk, Joseph P Foley, Brian J Bolognese, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbitPatricia L Podolin, Brian J Bolognese, James J Foley, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitorPatricia L Podolin, Brian J Bolognese, Donald C Carpenter, et al.Respiratory Medicine|March 30, 2016
Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPDM S Patel, A V Donaldson, A Lewis, et al.Prostaglandins & Other Lipid Mediators|February 26, 2013
In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitorPatricia L Podolin, Brian J Bolognese, Joseph F Foley, et al.Journal of Medicinal Chemistry|April 1, 2016
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based DiscoveryThomas G Davies, William E Wixted, Joseph E Coyle, et al.Pageof 6